Maternity General: Administration of Rh (D) Immunoglobulin (Anti D) - WSLHD
||V1.0 July 2004
|This Version Update
||30 June 2020
|Drug Commitee Approval
||30 June 2020
NB: This document will not necessarily apply in all circumstances. It does not replace professional and/or clinical judgement. It may be amended/withdrawn at any time. Printed copies should not be relied upon. ALWAYS refer to the electronic copy. WSYD-GL203035.pdf • Release 1
Purpose and Scope
- This document outlines the WSLHD RhD Immunoglobulin (Anti D) administration recommendations for Rh negative pregnant and postnatal women without pre-formed (immune) Rh D antibodies in order to prevent the development of Rh D Alloimmunisation.
- The procedure covers Anti D administration advice for both routine prophylactic administration (28 / 34 weeks and postpartum) and non-routine administration necessitated by sensitizing events.
- The dosing schedule is as per the tables over page
- The procedure does not address the management of the Rh negative woman who already has pre-formed Anti D antibodies.
- This procedure applies to all medical and midwifery staff caring for pregnant Rh Negative women at Auburn, Blacktown and Westmead Hospitals.
- Staff will understand the reasons for and will comply with the appropriate recommendation and administration of Rd (D) Immunoglobulin to Rh (D) negative women without pre-formed Anti D antibodies.
Looking for General
Need to make a room booking?